Etiqueta: stem cell institute
-
What are the sources of the stem cells used at Stem Cell Institute in Panama?
Lately, especially on our Facebook Page many people are asking us, «What is the source of the stem cells?» At the Stem Cell Institute, we use two types of stem cells. Primarily, we use allogeneic mesenchymal stem cells harvested from human umbilical cord tissue. In addition to allogeneic mesenchymal stem cells, our spinal cord injury…
-
Inside High School Football Report on Hall of Fame Coach and Stem Cell Recipient, Sam Harrell
Sam, who suffers from multiple sclerosis, was forced to retire as Ennis (Texas) High School’s head football coach due to his debilitating symptoms. Sam’s first two treatments using stem cells harvested from his own fat did not yield long lasting, positive results. However, after his third and fourth trips to the Stem Cell Institute in…
-
Clinical Trials for Multiple Sclerosis and Rheumatoid Arthritis using Umbilical Cord Tissue Mesenchymal Stem Cells
Stem Cell Institute and Medistem Panama founder, Neil Riordan, PhD discusses clinical trials for multiple sclerosis and rheumatoid arthritis using umbilical cord tissue-derived mesenchymal stem cells at our fall stem cell seminar in San Antonio. For more information about these trials and others, please visit www.translationalbiosciences.com. The multiple sclerosis trial is full but the RA…
-
Roberta F. Shapiro DO, FAAPM&R: “A New York Doctor’s Path to Panama» – A Stem Cell Therapy Video Lecture
Special Guest Speaker, Roberta F. Shapiro DO, FAAPM&R speaks about: “A New York Doctor’s Path to Panama” at the Stem Cell Institute’s Stem Cell Therapy Public Seminar in New York City on May 17, 2014. Dr. Shapiro discusses how she discovered the Stem Cell Institute and why she started referring her patients to Panama for…
-
After FDA Approval, Duchenne’s Muscular Dystrophy Patient Receives First Umbilical Cord Stem Cell Treatment in the United States
Ryan Benton, a 28 year-old Duchenne’s muscular dystrophy patient from Wichita, Kansas, received his first umbilical cord tissue-derived mesenchymal stem cell treatment yesterday at Asthma and Allergy Specialists of Wichita, KS following US FDA approval of his doctor’s application for a single patient, investigational new drug (IND) for compassionate use. Wichita, KS (PRWEB) September 10,…